EUVIMEDEUVIMED entdecken
Crossref

Morphological Spectrum of Pediatric Liver Diseases: An Institutional Experience

Dharm Raj Maurya, Priyank Verma, Sandeep Kumar Baranwal

International Journal of Current Pharmaceutical Review and Research · 05.03.2026 · 18 (03)

DOI: 10.25258/ijcpr.18.3.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 05.03.2026. Verfasst von Dharm Raj Maurya und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric liver diseases encompass a broad spectrum of disorders with diverse etiologies, clinical presentations, and outcomes. Histopathological examination of liver biopsy specimens plays a crucial role in establishing the diagnosis, determining disease severity, and guiding clinical management. The present study was undertaken to evaluate the morphological spectrum of pediatric liver diseases encountered in a tertiary care institution. Material and Methods: This retrospective descriptive study was conducted in the Department of Pathology of a tertiary care teaching hospital. A total of 112 liver biopsy specimens obtained from pediatric patients aged ≤18 years were included in the study. Relevant clinical details and laboratory data were collected from medical records. Biopsy specimens were fixed in 10% neutral buffered formalin, processed routinely, and stained with hematoxylin and eosin. Special stains were applied when indicated. Histopathological evaluation was performed to determine the morphological diagnosis and to assess the degree of hepatic fibrosis. Data were analyzed using descriptive statistics and presented as frequencies and percentages.

Results

Among the 112 cases, the majority of patients were in the 1–5 years age group (32.1%), followed by children younger than 1 year (25.0%). Males constituted 57.1% of the study population. The most common clinical indication for liver biopsy was persistent jaundice (33.9%), followed by hepatomegaly or hepatosplenomegaly (25.0%). Histopathological evaluation revealed neonatal hepatitis (23.2%) as the most frequent diagnosis, followed by biliary atresia (16.1%) and glycogen storage disease (12.5%). Non-alcoholic fatty liver disease (10.7%), autoimmune hepatitis (8.9%), and chronic hepatitis (8.9%) were also observed. When categorized broadly, cholestatic disorders accounted for 39.3%, followed by metabolic liver diseases (25.0%) and inflammatory liver diseases (17.9%). Evaluation of fibrosis demonstrated no fibrosis in 35.7%, mild fibrosis in 28.6%, moderate fibrosis in 21.4%, and advanced fibrosis or cirrhosis in 14.3% of cases.

Conclusion

Pediatric liver diseases show considerable histopathological diversity, with cholestatic and metabolic disorders being the most prevalent. Liver biopsy remains an essential diagnostic modality for accurate disease characterization and assessment of hepatic fibrosis in pediatric patients.

Zitieren

APA

Maurya, D. R., Verma, P., & Baranwal, S. K. (2026). Morphological Spectrum of Pediatric Liver Diseases: An Institutional Experience. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.23

Vancouver

Maurya DR, Verma P, Baranwal SK. Morphological Spectrum of Pediatric Liver Diseases: An Institutional Experience. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.23

BibTeX
@article{Maurya2026,
  author = {Maurya, Dharm Raj and Verma, Priyank and Baranwal, Sandeep Kumar},
  title = {Morphological Spectrum of Pediatric Liver Diseases: An Institutional Experience},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {03},
  doi = {10.25258/ijcpr.18.3.23}
}
Kostenlos starten →